1. The constitutively active PKG II mutant effectively inhibits gastric cancer development via a blockade of EGF/EGFR-associated signalling cascades. (31st January 2018) Authors: Wu, Yan; Yuan, Miaomiao; Su, Wenbin; Zhu, Miaolin; Yao, Xiaoyuan; Wang, Ying; Qian, Hai; Jiang, Lu; Tao, Yan; Wu, Min; Pang, Ji; Chen, Yongchang Journal: Therapeutic advances in medical oncology Issue: Volume 10(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗